Cleared Traditional

K252608 - AI-Rad Companion Prostate MR

K252608 is the FDA 510(k) clearance for AI-Rad Companion Prostate MR by Siemens Healthcare GmbH. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K252608 · Siemens Healthcare GmbH · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2025
Decision
22d
Days
Class 2
Risk

K252608 is an FDA 510(k) clearance for the AI-Rad Companion Prostate MR. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens Healthcare GmbH (Erlanger, DE). The FDA issued a Cleared decision on September 9, 2025 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Siemens Healthcare GmbH devices

Submission Details

510(k) Number K252608 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2025
Decision Date September 09, 2025
Days to Decision 22 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 107d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
Prithul Bom

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K252608.
uWS-Angio Pro
K250045 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2025
uWS-Angio
K250040 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2025
Minimally Invasive Prostate Surgery Navigation System(Model:AmaKris SR1-A-2)
K242314 · Augment Intelligent Medical System (China) Co., Ltd. · Sep 2025
Image Suite
K251168 · Carestream Health, Inc. · Sep 2025
SurgiTwin
K250290 · Twinsight · Aug 2025
Rapid DeltaFuse
K252526 · Ischemaview, Inc. · Aug 2025